Q-Line Biotech Limited

investing or financing cash flows. Cash flows from operating, investing and financing activities of the Company are segregated, accordingly.

### C. CHANGES IN ACCOUNTING POLICIES IN THE YEARS COVERED IN THE CONSOLIDATED RESTATED FINANCIALS

There was no change in accounting policies, which needs to be adjusted in the Consolidated Restated Financial Statement, except accounting of gratuity which was accounted on cash basis in the FY 2022-23 and FY 2023-24, however during the restatement Company has accounted such retirement benefits on the basis of actuarial valuation certificate in accordance with AS 15 (Revised).

### D. NOTES ON RESTATEMENTS MADE IN THE CONSOLIDATED RESTATED FINANCIALS

1. The financial statements including other financial information have been prepared after making such regroupings and adjustments, considered appropriate to comply with the requirement of the Companies Act, 2013, schedule III and Accounting Standard wherever required. As result of these regroupings and adjustments, the amount reported in the financial statements/information may not necessarily be same as those appearing in the respective audited financial statements for the relevant years.

2. Amount due to entities covered under Micro, Small and Medium Enterprises as defined in the Micro, Small, Medium Enterprises Development Act, 2006, have been reported basis of the parties identified by the management and relied upon by us.

3. **Realizations:**

The Company evaluated the carrying amounts of property, plant and equipment, Intangible assets, investments, inventories, loans and advances, receivables and other current assets. In developing the assumptions relating to the possible future uncertainties, the Company, as at the date of approval of these Restated financials has used internal and external sources on the expected future performance of the Company and management expects the carrying amount of these assets will be recovered and sufficient liquidity is available to fund the business operations for at least another 12 months. Due to any unforeseen circumstances the final impact on the Company's assets in future may differ from that estimate as at the date of approval of these Restated Financials.

4. **Contractual liabilities**

All other material contractual liabilities connected with business operations of the Company have been appropriately provided for in the Restated financial statements.

5. **Amounts in the financial statements**

Amounts in the financial statements are reported in Indian Rupees in lakhs and rounded off to second digit of decimal. Figures in brackets indicate negative values.